Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1309, 2001-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bisoprolol cost-effective addition in CHF in Sweden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. :
Carvedilol "highly cost-effective" for CHF in Japan
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 447, 2004-01 ,pp. :
Ramipril `highly cost-effective' in Sweden
Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. :
Most cost-effective therapies for urinary incontinence in Sweden . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 644, 2012-01 ,pp. :
Boceprevir a cost-effective addition in HCV therapy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 671, 2013-01 ,pp. :